Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding

Sabnam Nasrin Choudhury1, Tarikul Huda Mazumder1, Sahidul Saikia2

  • 1Molecular Medicine Laboratory, Department of Zoology, Moinul Hoque Choudhury Memorial Science College, Algapur, Hailakandi, Assam 788150, India.

Mutation Research
|May 5, 2026
PubMed

Insights

This study uncovers key microRNA-mRNA interactions in esophageal cancer (ESCA). Identifying these regulatory networks, like hsa-miR-30d-5p and CHST2, is crucial for understanding ESCA progression and developing new therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Esophageal cancer (ESCA) is a highly lethal malignancy with poor prognosis.
  • MicroRNAs (miRNAs) are key regulators in cancer, offering diagnostic and therapeutic potential.

Purpose of the Study:

  • To investigate miRNA-mRNA interactions in esophageal cancer (ESCA) using in silico methods.
  • To identify potential regulatory nodes driving tumor progression in ESCA.

Main Methods:

  • Selected 14 overexpressed genes in esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC).
  • Utilized TargetScanHuman and miRDB for miRNA target prediction (score ≥90).
  • Performed Gene Ontology (GO) analysis and TCGA-based validation for functional relevance.

Main Results:

  • Identified multi-miRNA targeting and stable miRNA-mRNA interactions with potential silencing capabilities.
  • Found target genes involved in transcriptional regulation, apoptosis inhibition, immune response, and cell signaling.
  • Validated a subset of interactions, notably the inverse correlation between hsa-miR-30d-5p and CHST2.

Conclusions:

  • Emphasizes the importance of integrating predictive and expression data for identifying functional miRNA-mRNA interactions in ESCA.
  • Highlights potential regulatory mechanisms in ESCA pathogenesis.
  • Suggests miRNAs as promising targets for future ESCA diagnostics and therapeutics.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K